EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry‐Based Case–Control Study

Asger Ahlmann Bech iD, Mia Daugaard Madsen, Annika Vestergaard Kvist, Peter Vestergaard, Nicklas Højgaard-Hessellund Rasmussen

Journal of Diabetes · 2025

DOI: 10.1111/1753-0407.70076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes, 2025. Verfasst von Asger Ahlmann Bech und 4 weiteren Autor:innen. Beteiligte Einrichtung: Steno Diabetes Center North Denmark, Aalborg University Hospital, Gistrup, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Diabetes Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danish Diabetes and Endocrine Academy, Novo Nordisk Foundation, Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aimed to investigate the association between cardiovascular risk factors and major adverse cardiovascular events (MACE) in people with type 2 diabetes, while assessing potential changes over time.

Methods

Utilizing data from Danish registries, this study identified people with type 2 diabetes between 2002 and 2021 ( n = 372 328) and subdivided them into two 10‐year time periods: TP1: 2002–2011 and TP2: 2012–2021, and further categorized into cases and controls. Cases were defined as having suffered a first‐time three‐point MACE ( n TP1 = 12 713, n TP2 = 8981) and matched 1:1 with controls on age, sex, and type 2 diabetes duration. Exposures were preselected diabetes complications and comorbidities.

Results

Fewer were affected by MACE during TP2 compared to TP1 ( p < 0.001). Diabetes complications associated with MACE were nephropathy (OR TP1 = 1.54, 95% CI 1.30–1.83, OR TP2 = 1.47, 95% CI 1.20–1.79), neuropathy (OR TP1 = 2.02, 95% CI 1.84–2.21 OR TP2 = 1.58, 95% CI 1.44–1.73) and retinopathy (OR TP1 = 1.10, 95% CI 0.98–1.23, OR TP2 = 1.38, 95% CI 1.17–1.63). Comorbidities associated with MACE included hypertension (OR TP1 = 1.30, 95% CI 1.22–1.38 OR TP2 = 1.31, 95% CI 1.22–1.41), atrial flutter or fibrillation (OR TP1 = 1.46, 95% CI 1.35–1.58, OR TP2 = 1.37, 95% CI 1.26–1.50), heart failure (OR TP1 = 1.53, 95% CI 1.401.67‐, OR TP2 = 1.37, 95% CI 1.23–1.54) and hypercholesterolemia (OR TP1 = 1.13, 95% CI 1.07–1.20, OR TP2 = 1.02, 95% CI 0.96–1.10). Hypercholesterolemia ( p = 0.038) and neuropathy ( p = 0.038) exhibited a significant decrease in association with MACE between the time periods.

Conclusions

The prevalence of first‐time MACE decreased over time, despite a relatively stable prevalence of type 2 diabetes. Several diabetes‐related complications and comorbidities were significantly associated with MACE. The associations of neuropathy and hypercholesterolemia with MACE lessened over time, suggesting potential improvements in risk management or treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Cardiovascular DiseasesDiabetes ComplicationsHumansMaleFemaleDenmarkRegistriesCase-Control StudiesComorbidityMiddle AgedAgedRisk Factors

Stichwörter der Autor:innen

cardiovascular diseasecomorbiditydiabetes complicationsmajor adverse cardiovascular eventsmultimorbiditytype 2 diabetes mellitus

Autor:innen und Institutionen

  • Steno Diabetes Center North Denmark, Aalborg University Hospital, Gistrup, Denmark.
  • Department of Clinical Medicine and Endocrinology, Aalborg University Hospital, Aalborg, Denmark.

ORCID-Profile: Asger Ahlmann Bech

Förderung

  • Danish Diabetes and Endocrine Academy
  • Novo Nordisk Foundation
  • Novo Nordisk Fonden

Zitieren

APA

Bech, A. A., Madsen, M. D., Kvist, A. V., Vestergaard, P., & Rasmussen, N. H. (2025). Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry‐Based Case–Control Study. Journal of Diabetes. https://doi.org/10.1111/1753-0407.70076

Vancouver

Bech AA, Madsen MD, Kvist AV, Vestergaard P, Rasmussen NH. Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry‐Based Case–Control Study. Journal of Diabetes. 2025. doi:10.1111/1753-0407.70076

BibTeX
@article{Bech2025,
  author = {Bech, Asger Ahlmann and Madsen, Mia Daugaard and Kvist, Annika Vestergaard and Vestergaard, Peter and Rasmussen, Nicklas Højgaard-Hessellund},
  title = {Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry‐Based Case–Control Study},
  journal = {Journal of Diabetes},
  year = {2025},
  doi = {10.1111/1753-0407.70076}
}
Kostenlos starten →